<address id="cansv"></address>
<s id="cansv"><sub id="cansv"></sub></s>
    <s id="cansv"></s>
    <span id="cansv"><input id="cansv"></input></span>
      <label id="cansv"></label>
      <s id="cansv"></s>

      <strike id="cansv"></strike>

      1. <s id="cansv"><sub id="cansv"><rt id="cansv"></rt></sub></s>
      2. <label id="cansv"></label>
      3. 掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
          
        客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  關于我們  聯系我們
        產品中心-北京博奧森生物技術有限公司
        首頁 > 產品中心 > 一抗 > 產品信息
        CD59 Recombinant Rabbit mAb (bsm-60603R)  
        訂購熱線:400-901-9800
        訂購郵箱:sales@bioss.com.cn
        訂購QQ:  400-901-9800
        技術支持:techsupport@bioss.com.cn
        25ul/800.00元
        50ul/1400.00元
        100ul/2500.00元
        大包裝/詢價

        產品編號 bsm-60603R
        英文名稱 CD59 Recombinant Rabbit mAb
        中文名稱 CD59重組兔單抗
        別    名 CD59 glycoprotein; CD59 molecule(CD59 blood group); 1F5 antigen; 20 kDa homologous restriction factor; MAC-inhibitory protein; Membrane attack complex inhibition factor; Membrane inhibitor of reactive lysis; MEM43 antigen; MACIF; 1F5; EJ16; EJ30; EL32; G344; MIN1; MIN2; MIN3; MIRL; HRF20; MACIF; MEM43; MIC11; MSK21; 16.3A5; HRF-20; MAC-IP; p18-20; CD59_HUMAN.  
        研究領域 心血管  免疫學  信號轉導  干細胞  
        抗體來源 Rabbit
        克隆類型 Recombinant
        克 隆 號 E10F7
        交叉反應 Human
        產品應用 WB=1:500-2000,IHC-P=1:50-200,IHC-F=1:50-200,IF=1:50-200
        not yet tested in other applications.
        optimal dilutions/concentrations should be determined by the end user.
        理論分子量 9 kDa
        檢測分子量
        細胞定位 細胞膜 
        性    狀 Liquid
        濃    度 1mg/ml
        免 疫 原 KLH conjugated synthetic peptide derived from human CD59 
        亞    型 IgG
        純化方法 affinity purified by Protein A
        緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
        保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
        注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
        PubMed PubMed
        產品介紹 This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]

        Function:
        Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase.
        The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.

        Subunit:
        Interacts with T-cell surface antigen CD2.

        Subcellular Location:
        Cell membrane; Lipid-anchor, GPI-anchor. Secreted. Note=Soluble form found in a number of tissues.

        Post-translational modifications:
        N- and O-glycosylated. The N-glycosylation mainly consists of a family of biantennary complex-type structures with and without lactosamine extensions and outer arm fucose residues. Also significant amounts of triantennary complexes (22%). Variable sialylation also present in the Asn-43 oligosaccharide. The predominant O-glycans are mono-sialylated forms of the disaccharide, Gal-beta-1,3GalNAc, and their sites of attachment are probably on Thr-76 and Thr-77. The GPI-anchor of soluble urinary CD59 has no inositol-associated phospholipid, but is composed of seven different GPI-anchor variants of one or more monosaccharide units. Major variants contain sialic acid, mannose and glucosamine Sialic acid linked to an N-acetylhexosamine-galactose arm is present in two variants.
        Glycated. Glycation is found in diabetic subjects, but only at minimal levels in nondiabetic subjects. Glycated CD59 lacks MAC-inhibitory function and confers to vascular complications of diabetes.

        DISEASE:
        CD59 deficiency (CD59D) [MIM:612300]: A deficiency resulting in chronic complement-mediated intravascular hemolysis, anemia, hemoglobinuria and thrombosis. Note=The disease is caused by mutations affecting the gene represented in this entry.

        Similarity:
        Contains 1 UPAR/Ly6 domain.

        SWISS:
        P13987

        Gene ID:
        966

        Database links:

        Entrez Gene: 966 Human

        Entrez Gene: 12509 Mouse

        Omim: 107271 Human

        SwissProt: P13987 Human

        SwissProt: O55186 Mouse

        Unigene: 278573 Human

        Unigene: 709466 Human

        Unigene: 710641 Human

        Unigene: 247265 Mouse



        反應性溶血膜抑制蛋白(CD59)是血細胞膜上糖化磷脂酰肌醇(GPI)錨定蛋白,具有抑制補體系統激活,參與信號傳遞,有協助T淋巴細胞活化功能,CD59在補體調節過程中起著很主要的作用。
        產品圖片
        25 ug total protein per lane of various lysates (see on figure) probed with CD59 monoclonal antibody, unconjugated (bsm-60603R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.
        Paraformaldehyde-fixed, paraffin embedded Human Placenta; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        Paraformaldehyde-fixed, paraffin embedded Human gastric cancer; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        Paraformaldehyde-fixed, paraffin embedded Human Stomach; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        Paraformaldehyde-fixed, paraffin embedded Human Testicles; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        Paraformaldehyde-fixed, paraffin embedded Human Tonsil; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        Paraformaldehyde-fixed, paraffin embedded Human Colon Cancer; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        Paraformaldehyde-fixed, paraffin embedded Human Lung Cancer; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CD59 Monoclonal Antibody, Unconjugated (bsm-60603R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.
        版權所有 2004-2026 m.radiasunchina.com 北京博奧森生物技術有限公司
        通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
        通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
        京ICP備05066980號-1         京公網安備110107000727號
        国产剧情演绎系列丝袜高跟|一级毛片av性爱黄色网站|欧美三级午夜理伦三级|国产av巨作情欲放纵|亚洲 欧美 中文 日韩aⅴ
        <address id="cansv"></address>
        <s id="cansv"><sub id="cansv"></sub></s>
        <s id="cansv"></s>
        <span id="cansv"><input id="cansv"></input></span>
          <label id="cansv"></label>
          <s id="cansv"></s>

          <strike id="cansv"></strike>

          1. <s id="cansv"><sub id="cansv"><rt id="cansv"></rt></sub></s>
          2. <label id="cansv"></label>